NEW ARTICLE: Johnson & Johnson to acquire $2 billion drug developer “Ambrx Biopharma” to treat Turbo Cancers with same tech as Pfizer’s $43 billion Seagen acquisition. Both set their sights on 2025 Cancer TSUNAMI
Pfizer & Moderna COVID-19 mRNA Vaccines cause Turbo Cancers, this is now well acknowledged by respected physicians around the world.
Last month, Pfizer closed a $43 billion acquisition of Seagen, to boost its ability to treat 7 of the top 10 Turbo Cancers caused by its COVID-19 mRNA Vaccine.
Top 5 Turbo Cancers: lymphoma, glioblastoma, breast, colon, lung
Top 10 Turbo Cancers: leukemia, melanoma, sarcomas, testicular/ovarian, kidney
Pfizer expects a “Cancer Tsunami” to hit in 2025
Moderna is rushing its melanoma mRNA Cancer vaccine to have expedited approval by 2025.
Johnson & Johnson is the latest to want a piece of the Turbo Cancer treatment pie before 2025.
This $2 billion acquisition of Ambrx Biopharma gives them the same cancer treatment tech as Pfizer - ADCs.
ADC: “a class of therapeutics that combines the specificity of monoclonal antibodies with the potency of cytotoxic drugs, aiming to target and destroy cancer cells more effectively”
Johnson & Johnson, for $2 billion, adds new ability to treat Breast Turbo Cancer, Prostate Turbo Cancer and Kidney Turbo Cancer with this acquisition.
They also overpaid by more than 100% of the current Ambrx Biopharma stock price. Acquisition expected to close in mid 2024.
Many pharmaceutical companies are rushing to position themselves to profit from treating a tsunami of cancers that they are all expecting to hit starting in 2025.
Dec.14, 2023 - Pfizer closed a $43 billion acquisition to treat several turbo cancers and expects to “fill a gap” for the period 2025-2030.
Dec.14, 2023 - Moderna targets new mRNA Cancer vaccine to treat melanoma to be available by 2025
Jan.8, 2024 - Johnson & Johnson to acquire $2 billion cancer drug company that uses same tech as Pfizer, to “fill a revenue gap starting in 2025”
Jan.10, 2024 - BioNTech expects to return to revenue growth in 2025, when its COVID vaccine business would bottom out, and it would invest to “scale up its oncology business thereafter”
Many companies that have new blood tests or light tests to quickly detect cancer are all targeting 2025 for their launch. I provide examples.
Dozens of giant Cancer Centers are going up all across the US, Canada, Australia and UK - all of them are opening in 2025.
They’re ready for the 2025 Cancer TSUNAMI.
Are you?
HOPEFULLY THEY GET A TREATMENT BEFORE FISH REVERSE KARMA KICKS IN HUH?
GUESS WHAT STORM NEVER DID AND POSTED ON THIS BOARD THAT GOT COVERED UP?
DON’T TAKE THE VACCINE….
THANK THE CRIMINAL LOSERS THAT ARE TRYING TO BLOCK STORM’S POST……
LIKE STORM TOLD 51 NORTHAM HE SHOULD BE CRIMINALLY CHARGED….
